Anavex Life Sciences Corp (AVXL)

[indialong]

Not terrible. Not a surprise.

From the agreement:

"The table above assumes for illustrative purposes that an aggregate of 6,711,410 shares of our common stock are sold pursuant to this prospectus supplement and the accompanying prospectus at a price of $2.98 per share, the last reported sale price of our common stock on the Nasdaq Capital Market on June 7, 2019, for aggregate gross proceeds of $20 million"

Price is now 3.25, so even less dilution as compared to June 7th.